Endo Pharmaceuticals, Inc. is recalling 372,938 bottles of Calcitonin Salmon Nasal Spray (calcitonin-salmon) due to the presence of impurities and the medication being subpotent, meaning it is not as strong as it should be. The medication, which was manufactured by Par Pharmaceutical, failed testing for both known and unknown impurities and did not meet the required levels of active ingredient in specific batches. No incidents or injuries have been reported to date.
A subpotent drug may not effectively treat the medical condition for which it was prescribed, and high levels of impurities can lead to unexpected side effects or reduced safety. Patients using this spray may not receive the intended therapeutic benefit of the medication.
You have 2 options:
Manufactured by Par Pharmaceutical, Chestnut Ridge, NY 10977
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.